BRITTNEY EDGE: Open Payments
NPI 1558871830 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$945 in 46 payments from 12 companies in 2025. Trend: 2023 $784 · 2024 $682 · 2025 $945
Food & beverage: $926Education: $19
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 11 | $165 |
| Novartis Pharmaceuticals Corporation | 11 | $136 |
| Novo Nordisk Inc | 1 | $116 |
| PFIZER INC. | 6 | $115 |
| Medtronic, Inc. | 1 | $101 |
| E.R. Squibb & Sons, L.L.C. | 5 | $78 |
| SCPHARMACEUTICALS INC. | 3 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: VERQUVO, LEQVIO, Wegovy, SYMPLICITY G3, CAMZYOS, FUROSCIX, ELIQUIS, VYNDAQEL.
Industry payments across AL — which companies pay providers there.
